PMID- 28558380 OWN - NLM STAT- MEDLINE DCOM- 20170711 LR - 20190212 IS - 1421-9778 (Electronic) IS - 1015-8987 (Linking) VI - 42 IP - 1 DP - 2017 TI - Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma. PG - 373-382 LID - 10.1159/000477481 [doi] AB - BACKGROUND/AIMS: Circulating tumor cells (CTCs) are valuable in both basic research and clinical application for cancer management. In the current study, we evaluated the diagnostic value of CTCs in pancreatic ductal adenocarcinoma (PDAC). METHODS: In total, 143 blood samples from 95 consecutively diagnosed PDAC patients and 48 healthy donors were collected. Combined data from immunostaining of CD45, DAPI and fluorescence in situ hybridization (FISH) with chromosome 8 centromere (CEP8) probe were used to identify CTCs. Cells with features of CD45-/DAPI+/CEP8>2 were detected as CTCs. RESULTS: CTCs were classified as triploid, tetraploid and multiploid based on chromosome 8 copy number. CTC subtype composition was significantly different among groups. Both subtype number and total CTC number were significantly increased in PDAC patients, compared to healthy controls. Total CTC number had 75.8% sensitivity and 68.7% specificity at a cutoff value of 2 cells/3.2 mL. This study is the first to report that CTC subtype number is also useful in cancer diagnosis. Sensitivity was 53.7% and specificity was 85.4% at a cutoff point of 2 CTC subtypes. The diagnostic value of both total CTC number and CTC subtype number was a little poorer than CA199. CONCLUSIONS: Both CTC subtype and total CTC number may serve as potential biomarkers for PDAC. CI - (c) 2017 The Author(s). Published by S. Karger AG, Basel. FAU - Liu, Han AU - Liu H AD - Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai, China. FAU - Sun, Bo AU - Sun B AD - Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, China. FAU - Wang, Shengnan AU - Wang S AD - Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai, China. FAU - Liu, Congjin AU - Liu C AD - Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai, China. FAU - Lu, Yun AU - Lu Y AD - Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai, China. FAU - Li, Ding AU - Li D AD - Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai, China. FAU - Liu, Xingdang AU - Liu X AD - Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai, China. LA - eng PT - Journal Article DEP - 20170525 PL - Germany TA - Cell Physiol Biochem JT - Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology JID - 9113221 RN - 0 (Antigens, Tumor-Associated, Carbohydrate) RN - 0 (Biomarkers, Tumor) RN - 0 (carbohydrate antigen 199, human) RN - EC 3.1.3.48 (Leukocyte Common Antigens) SB - IM MH - Aged MH - Antigens, Tumor-Associated, Carbohydrate/blood MH - Area Under Curve MH - Biomarkers, Tumor/*metabolism MH - Carcinoma, Pancreatic Ductal/*diagnosis/metabolism/pathology MH - Case-Control Studies MH - Chromosomes, Human, Pair 8/genetics MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Leukocyte Common Antigens/metabolism MH - Luminescent Measurements MH - Male MH - Middle Aged MH - Neoplastic Cells, Circulating/*metabolism MH - Pancreatic Neoplasms/*diagnosis/metabolism/pathology MH - ROC Curve MH - Tetraploidy MH - Triploidy OTO - NOTNLM OT - Aneuploidy OT - Biomarker OT - Circulating tumor cells OT - Pancreatic cancer EDAT- 2017/05/31 06:00 MHDA- 2017/07/14 06:00 CRDT- 2017/05/31 06:00 PHST- 2016/09/26 00:00 [received] PHST- 2017/03/23 00:00 [accepted] PHST- 2017/05/31 06:00 [pubmed] PHST- 2017/07/14 06:00 [medline] PHST- 2017/05/31 06:00 [entrez] AID - 000477481 [pii] AID - 10.1159/000477481 [doi] PST - ppublish SO - Cell Physiol Biochem. 2017;42(1):373-382. doi: 10.1159/000477481. Epub 2017 May 25.